msc綜述new-資料下載頁
2025-08-05 01:16本頁面
【正文】 tem cell–lymphocyte interaction. Haematologica 2007, 92:881888.14. Tabera S, PerezSimon JA, DiezCampelo M, et al. The effect of mesenchymal stem cells on the viability, proliferation and differentiation of Blymphocytes. Haematologica 2008, 93:13011309.15. Asari S, Itakura S, Ferreri K, et al. Mesnchymal stem cells suppress Bcell terminal differentiation. Exp Hematol 2009,37:60461516. Nauta AJ, Kruisselbrink AB, Lurvink E, et al. Mesenchymal stem cells inhibit generation and function of both CD34+derived and monocyte derived dendritic cells. J Immunol 2006, 177:20802087.17. Sotiropoulou PA, Perez SA, Gritzapis AD, et al. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 2006, 24:7485.18. Raffaghello L, Bianchi G, Bertolotto M,et al. Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. Stem Cells 2008, 26:151162.19. Nemeth K, Leelahavanichkul A, Yuen PS, et al Bone marrow stromal cells attenuate sepsis via prostaglandin E2dependent reprogramming of host macrophages to increase their interleukin10 production. Nat Med 2009, 15:4249.20. Ball LM, Bernardo ME, Roelofs H,et al. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stemcell transplantation. Blood 2007, 110:27642767.21. Le Blanc K, Frassoni F, Ball L,et al. Mesenchymal stem cells for treatment of steroidresistant, severe, acute graftversushost disease: a phase II study. Lancet 2008, 371:15791586. 22. Ringden O, Blanc KL . Mesenchymal stem cells for treatment of acute and chronic graftversushost disease, tissue toxicity and hemorrhages. Best Practice amp。 Research Clinical Haematology 2011, 24 : 65–72. 23. Chao YH, Peng CT, Ham HJ, et a1. Poor potential of proliferation and diferentiation in bone malTow mesenehymal stem cells derived from children with severe aplastic anemia. Ann Hematol, 2010, 89: 715723．24. Bacigalupo A, Valle M, Podesta M, et a1. Tcell suppression mediated by mesenchymal stem cells is deficient in patients with severeaplastie anemia．Exp Hematol, 2005, 33: 81982725. 黃穎，鄭翠玲，楊少光等。骨髓間充質(zhì)干細(xì)胞對(duì)免疫介導(dǎo)再生障礙性貧血的治療。中國(guó)組織工程研究與臨床康復(fù)。2011, 15:4145. 10
范文總結(jié)相關(guān)推薦
鄂ICP備17016276號(hào)-1